Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

58Sunliner

(5,886 posts)
3. It's not a guarantee.
Tue Apr 28, 2020, 02:51 PM
Apr 2020

"Researchers at Fudan University in Shanghai analyzed blood samples from 175 recovered coronavirus patients after they were discharged from hospital and found surprisingly low levels of antibodies against the virus.

Around 30% of patients had antibody levels that were so low, researchers suspect they might not be protected against reinfection."

The ones who were the sickest, had the most immunity.

"This week marked the beginning of another clinical trial of a potential COVID-19 therapy, but rather unusually, this one targets human cells rather than the virus.-Last month, scientists showed that the drug, camostat mesylate, can prevent the novel coronavirus, SARS-CoV-2, from infecting lung cells in the lab."

https://www.weforum.org/agenda/2020/04/covid-19-three-top-science-stories-of-the-week/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+inside-the-world-economic-forum+%28Inside+The+World+Economic+Forum%29

Recommendations

0 members have recommended this reply (displayed in chronological order):

Thanks, safeinOhio Apr 2020 #1
Nobody knows. old guy Apr 2020 #2
It's not a guarantee. 58Sunliner Apr 2020 #3
Part of the problem is precisely Igel Apr 2020 #4
Latest Discussions»Editorials & Other Articles»Coronavirus Immunity: Can...»Reply #3